Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • plabaj
    Member
    • Oct 2010
    • 95

    #1

    MetaSUB Inter-City Challenge - CAMDA@ISMB/ECCB

    Founded in 2015, the MetaSUB International Consortium aims to create the world's only longitudinal metagenomic map of mass-transit systems and other public spaces across the globe. While Global City Sampling Day covered over 40 locations, the consortium has partnered with CAMDA for the first-ever multi-city analysis, with an early release of New York City, Boston, and Sacramento exclusive to MetaSUB and CAMDA.

    Analysis suggestions:
    • Biological: Compare organism fingerprints from public places across cities. Investigate organism sequences and biodiversity vs location. How diverse is each city – in terms of the numbers of bacteria, eukaryotes, viruses, plasmids, and antimicrobial resistance markers (AMRs)? Can we determine if each city has a distinct AMR profile?
    • Technical: Which computational tools have the highest sensitivity and specificity for species detection?


    Check also other CAMDA challenges!

    Join us for a stimulating scientific meeting and lively discussions in Prague 22-23 July 2017!

    Follow us on twitter @CAMDA_conf

    See you in Prague!
    Pawel Labaj
  • plabaj
    Member
    • Oct 2010
    • 95

    #2
    Submission Options

    There are two Submission Options:
    • Full methods research papers can be submitted to the regular ISMB Proceedings Track (note 26th of January ISMB Proceedings deadline!), specifying CAMDA as intended target audience.
    • Extended abstracts of late breaking methods research or analyses of the CAMDA challenge data sets can be submitted by the CAMDA submission deadline in May. Extended abstracts should include at least preliminary key results and figures. Based on the extended abstract, the scientific committee selects teams to present their work at the CAMDA conference, where updated results need to be shown.


    Check also other CAMDA challenges!

    Join us for a stimulating scientific meeting and lively discussions in Prague 22-23 July 2017!

    Follow us on twitter @CAMDA_conf

    See you in Prague!
    Pawel Labaj

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...